Results 191 to 200 of about 2,080,394 (268)

Peripheral cytotoxic immune profiles in hepatobiliary surgical patients. [PDF]

open access: yesFront Immunol
Li Z   +7 more
europepmc   +1 more source

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant   +11 more
wiley   +1 more source

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Development of a molecular marker for the Run8 gene for the selection of barley genotypes resistant to smut. [PDF]

open access: yesVavilovskii Zhurnal Genet Selektsii
Orlova EA   +5 more
europepmc   +1 more source

Minimum marker densities for accurate genomic predictions and heritability estimates in three major North American and European spruce species. [PDF]

open access: yesHeredity (Edinb)
Soro A   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy